4 oncology jobs found in Charlotte

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development. We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

Pharmaceutical Sales Representative - Primary Care (Entry Level or Specialty) Pharmaceutical Sales Rep - Job Description   We are a healthcare industry specialty distributor serving the healthcare and medical supply markets. We are driven to meet the needs of healthcare professionals in several therapeutic areas.  Our healthcare professional and physician customers benefit from a diverse group of products and services. Who are we looking for in our Pharmaceutical Sales Rep professionals? We are looking for healthcare and business-minded professionals, with successful sales track records who strive for organizational success, and seek career growth. What can you expect from a career with us as a Pharmaceutical Sales Representative? As a Pharmaceutical Sales Representative, you are responsible for driving profitable sales growth by developing, maintaining, and advancing accounts by regularly contacting medical offices,...

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.